{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:09:07Z","timestamp":1768406947372,"version":"3.49.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,2]]},"DOI":"10.7759\/cureus.91485","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T17:05:22Z","timestamp":1756832722000},"source":"Crossref","is-referenced-by-count":1,"title":["Myasthenia Gravis as a Manifestation of Aicardi\u2013Gouti\u00e8res Syndrome Due to a SAMHD1 Variant Successfully Treated With Baricitinib"],"prefix":"10.7759","author":[{"given":"Maria","family":"Kollia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Mouskou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lida","family":"Mentesidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeliki","family":"Syggelou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Anagnostopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despoina  N","family":"Maritsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3850","article-title":"Aicardi-Gouti\u00e8res syndrome and the type I interferonopathies","volume":"15","author":"Crow YJ","year":"2015","unstructured":"Crow YJ, Manel N. Aicardi-Gouti\u00e8res syndrome and the type I interferonopathies. Nat Rev Immunol. 2015, 15:429-40. 10.1038\/nri3850","journal-title":"Nat Rev Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12160","article-title":"Aicardi-Gouti\u00e8res syndrome: a model disease for systemic autoimmunity","volume":"175","author":"Lee-Kirsch MA","year":"2014","unstructured":"Lee-Kirsch MA, Wolf C, G\u00fcnther C. Aicardi-Gouti\u00e8res syndrome: a model disease for systemic autoimmunity. Clin Exp Immunol. 2014, 175:17-24. 10.1111\/cei.12160","journal-title":"Clin Exp Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-024-07824-x","article-title":"An overview of genetic mutations in Aicardi-Gouti\u00e8res syndrome in Iranian population","volume":"46","author":"Khalilian S","year":"2025","unstructured":"Khalilian S, Fathi M, Miryounesi M, Ghafouri-Fard S. An overview of genetic mutations in Aicardi-Gouti\u00e8res syndrome in Iranian population. Neurol Sci. 2025, 46:999-1007. 10.1007\/s10072-024-07824-x","journal-title":"Neurol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/a-2321-0597","article-title":"Neurological findings and a brief review of the current literature in a severe case of Aicardi-Gouti\u00e8res syndrome due to an IFIH1 mutation","volume":"55","author":"\u017deleznik M","year":"2024","unstructured":"\u017deleznik M, Vesnaver TV, Neubauer D, Soltirovska-\u0160alamon A. Neurological findings and a brief review of the current literature in a severe case of Aicardi-Gouti\u00e8res syndrome due to an IFIH1 mutation. Neuropediatrics. 2024, 55:337-40. 10.1055\/a-2321-0597","journal-title":"Neuropediatrics"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13413","article-title":"The prototypical interferonopathy: Aicardi-Gouti\u00e8res syndrome from bedside to bench","volume":"327","author":"Hofer MJ","year":"2024","unstructured":"Hofer MJ, Modesti N, Coufal NG, et al.. The prototypical interferonopathy: Aicardi-Gouti\u00e8res syndrome from bedside to bench. Immunol Rev. 2024, 327:83-99. 10.1111\/imr.13413","journal-title":"Immunol Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2010.03727.x","article-title":"Intracerebral large artery disease in Aicardi-Gouti\u00e8res syndrome implicates SAMHD1 in vascular homeostasis","volume":"52","author":"Ramesh V","year":"2010","unstructured":"Ramesh V, Bernardi B, Stafa A, et al.. Intracerebral large artery disease in Aicardi-Gouti\u00e8res syndrome implicates SAMHD1 in vascular homeostasis. Dev Med Child Neurol. 2010, 52:725-32. 10.1111\/j.1469-8749.2010.03727.x","journal-title":"Dev Med Child Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33359","article-title":"Familial Aicardi-Gouti\u00e8res syndrome due to SAMHD1 mutations is associated with chronic arthropathy and contractures","volume":"152A","author":"Dale RC","year":"2010","unstructured":"Dale RC, Gornall H, Singh-Grewal D, Alcausin M, Rice GI, Crow YJ. Familial Aicardi-Gouti\u00e8res syndrome due to SAMHD1 mutations is associated with chronic arthropathy and contractures. Am J Med Genet A. 2010, 152A:938-42. 10.1002\/ajmg.a.33359","journal-title":"Am J Med Genet A"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards S","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al.. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015, 17:405-24. 10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2022.10.013","article-title":"Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria","volume":"109","author":"Pejaver V","year":"2022","unstructured":"Pejaver V, Byrne AB, Feng BJ, et al.. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria. Am J Hum Genet. 2022, 109:2163-77. 10.1016\/j.ajhg.2022.10.013","journal-title":"Am J Hum Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003782","article-title":"Myasthenia crisis induced by pegylated-interferon in patient with chronic hepatitis C: a case report","volume":"95","author":"Baik SJ","year":"2016","unstructured":"Baik SJ, Kim TH, Kim HI, Rhie JY. Myasthenia crisis induced by pegylated-interferon in patient with chronic hepatitis C: a case report. Medicine (Baltimore). 2016, 95:e3782. 10.1097\/MD.0000000000003782","journal-title":"Medicine (Baltimore)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.028233","article-title":"Development of myasthenia gravis in two patients with multiple sclerosis following interferon beta treatment","volume":"75","author":"Dionisiotis J","year":"2004","unstructured":"Dionisiotis J, Zoukos Y, Thomaides T. Development of myasthenia gravis in two patients with multiple sclerosis following interferon beta treatment. J Neurol Neurosurg Psychiatry. 2004, 75:1079. 10.1136\/jnnp.2003.028233","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cells11071218","article-title":"Myasthenia gravis: an acquired interferonopathy?","volume":"11","author":"Payet CA","year":"2022","unstructured":"Payet CA, You A, Fayet OM, Dragin N, Berrih-Aknin S, Le Panse R. Myasthenia gravis: an acquired interferonopathy?. Cells. 2022, 11:10.3390\/cells11071218","journal-title":"Cells"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2001362","article-title":"Janus kinase inhibition in the Aicardi-Gouti\u00e8res syndrome","volume":"383","author":"Vanderver A","year":"2020","unstructured":"Vanderver A, Adang L, Gavazzi F, et al.. Janus kinase inhibition in the Aicardi-Gouti\u00e8res syndrome. N Engl J Med. 2020, 383:986-9. 10.1056\/NEJMc2001362","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/268557-myasthenia-gravis-as-a-manifestation-of-aicardi-goutires-syndrome-due-to-a-samhd1-variant-successfully-treated-with-baricitinib","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T17:05:23Z","timestamp":1756832723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/268557-myasthenia-gravis-as-a-manifestation-of-aicardi-goutires-syndrome-due-to-a-samhd1-variant-successfully-treated-with-baricitinib"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.91485","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,2]]}}}